high-beta sectors

• 10/19/2024

  Protagonist Therapeutics: Solid Outlook, But Is the Stock Worth It?

• 10/7/2024

  **Market Report – October 6, 2024**

• 

  10/5/2024

  **Stovall’s Market Outlook: Election, Fed, and What’s Next**

• 

  10/4/2024

  **US Dividend ETFs Surge After Fed Rate Cut**

• 9/30/2024

  **Pessimistic About a Soft Landing**